Cargando…

Mass spectrometry analysis of tau and amyloid‐beta in iPSC‐derived models of Alzheimer’s disease and dementia

Induced pluripotent stem cell (iPSC) technology enables the generation of human neurons in vitro, which contain the precise genome of the cell donor, therefore permitting the generation of disease models from individuals with a disease‐associated genotype of interest. This approach has been extensiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arber, Charles, Alatza, Argyro, Leckey, Claire A., Paterson, Ross W., Zetterberg, Henrik, Wray, Selina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613538/ https://www.ncbi.nlm.nih.gov/pubmed/33539581 http://dx.doi.org/10.1111/jnc.15315

Ejemplares similares

The PSEN1 E280G mutation leads to increased amyloid-β43 production in induced pluripotent stem cell neurons and deposition in brain tissue
por: Willumsen, Nanet, et al.
Publicado: (2022)

Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia
por: Kopach, Olga, et al.
Publicado: (2021)

Familial Alzheimer’s Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis
por: Arber, Charles, et al.
Publicado: (2021)

Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios
por: Toombs, Jamie, et al.
Publicado: (2018)

Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons
por: van der Kant, Rik, et al.
Publicado: (2019)

Deciphering tau-related dementia using human iPSC lines: electrophysiological perspectives of future studies
por: Kopach, Olga
Publicado: (2022)

Amyloid-beta 42 adsorption following serial tube transfer
por: Toombs, Jamie, et al.
Publicado: (2014)

Modeling of Frontotemporal Dementia Using iPSC Technology
por: Kim, Minchul, et al.
Publicado: (2020)

Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability
por: Silva, M. Catarina, et al.
Publicado: (2016)

Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons
por: Satir, Tugce Munise, et al.
Publicado: (2020)

iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease
por: Arber, Charles, et al.
Publicado: (2017)

Using Human iPSC-Derived Neurons to Model TAU Aggregation
por: Verheyen, An, et al.
Publicado: (2015)

Intracellular deposits of amyloid-beta influence the ability of human iPSC-derived astrocytes to support neuronal function
por: Konstantinidis, Evangelos, et al.
Publicado: (2023)

Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages
por: Haenseler, Walther, et al.
Publicado: (2017)

Author Correction: Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons
por: Satir, Tugce Munise, et al.
Publicado: (2020)

Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons
por: Oakley, Derek H., et al.
Publicado: (2021)

CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis
por: Samelson, Avi J., et al.
Publicado: (2023)

Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model
por: Manos, Justine D., et al.
Publicado: (2021)

Applications of iPSC-derived beta cells from patients with diabetes
por: Maxwell, Kristina G., et al.
Publicado: (2021)

Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
por: Robbins, Jacqueline P., et al.
Publicado: (2018)

Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity
por: Hu, Neng-Wei, et al.
Publicado: (2018)

Amyloid precursor protein processing in human neurons with an allelic series of the PSEN1 intron 4 deletion mutation and total presenilin-1 knockout
por: Arber, Charles, et al.
Publicado: (2019)

Mitochondrial hyperpolarization in iPSC-derived neurons from patients of FTDP-17 with 10+16 MAPT mutation leads to oxidative stress and neurodegeneration
por: Esteras, Noemí, et al.
Publicado: (2017)

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
por: Milà‐Alomà, Marta, et al.
Publicado: (2020)

Knockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities
por: Gabriele, Rebecca M. C., et al.
Publicado: (2022)

Aberrant iPSC-derived human astrocytes in Alzheimer's disease
por: Jones, V C, et al.
Publicado: (2017)

Modeling Alzheimer’s disease with iPSC-derived brain cells
por: Penney, Jay, et al.
Publicado: (2019)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

Stem cell models of Alzheimer’s disease: progress and challenges
por: Arber, Charles, et al.
Publicado: (2017)

Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells
por: Wren, Melissa C., et al.
Publicado: (2015)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Parkinson’s Disease Dementia: Synergistic Effects of Alpha-Synuclein, Tau, Beta-Amyloid, and Iron
por: Han, Jiajun, et al.
Publicado: (2021)

The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
por: Yin, Xiaomin, et al.
Publicado: (2021)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
por: Roda, Alejandro R., et al.
Publicado: (2022)

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays
por: van Harten, Argonde C., et al.
Publicado: (2021)

Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation
por: Mancini, Ross S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m0o7d4f622s67aig6n1jrbgcqd